ISRCTN ISRCTN13030013
DOI https://doi.org/10.1186/ISRCTN13030013
Secondary identifying numbers Ref No: B.30.2.ANK.0.21.63.00/824-02/9-8
Submission date
15/01/2015
Registration date
04/02/2015
Last edited
22/01/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Cigarette smoking is one of the major risk factors for gum disease. The aim in this study is to assess the impact of cigarette smoking on healthy and diseased gum tissue.

Who can participate?
Adult smokers and non-smokers

What does the study involve?
Samples will be obtained of the fluid secreted where the gums meet the teeth.

What are the possible benefits and risks of participating?
There are no known benefits to participants taking part in this study. There are no known risks to participants taking part in this study.

Where is the study run from?
Ondokuz Mayıs University (Turkey)

When is the study starting and how long is it expected to run for?
From September 2012 to March 2014

Who is funding the study?
Ondokuz Mayıs University (Turkey)

Who is the main contact?
Associate Professor Muge Lutfioglu

Contact information

Dr Muge Lutfioglu
Scientific

Ondokuz Mayıs University
Dental Faculty
Samsun
55139
Türkiye

ORCiD logoORCID ID 0000-0003-1499-5902

Study information

Study designCross-sectional observational study
Primary study designObservational
Secondary study designCross sectional study
Study setting(s)Hospital
Study typeOther
Participant information sheet A study population of smokers and nonsmokers was selected regarding the criteria: (i) to be ≥ 18 years of age and having ≥ 16 teeth, (ii) not to have previous periodontal therapy in the last 6 months, and (iii) not to have any systemic problems and regular/current (at least 6 weeks prior to data collection) chemotherapeutic regimens. Smoking status was determined as ≥ 5 years of duration and as ≥ 15 per day of consumption in all smokers, whereas non-smoking status included individuals who never smoked before.
Scientific titleInterleukin 8 and lipoxin a4 levels in the gingival crevicular fluid of smokers and non-smokers with different periodontal diseases: a cross-sectional study
Study objectivesInvestigate the effect of cigarette smoking on gingival crevicular fuid levels of interleukin 8 and lipoxin A4, cytokines that affect the polymorphonuclear functions in inflammatory response, in healthy individuals and those with periodontal disease because:
1. Cigarette smoking is one of the major risk factors for periodontal disease and has effects on the pathogenesis of the periodontal disease.
2. Smoking alters the host's response, including vascular function, neutrophil/monocyte activities, adhesion molecule expression, antibody production and cytokine and inflammatory mediator release.
3. Loss of proinflammatory mediators is the turn off signal for inflammation, ending subsequent responses passively
4. Resolution of inflammation and the return to homoeostasis is an active and highly regulated biochemical process that is thought to be programmed at the tissue level.
5. Failure to the remove the noxious products of smoking will have negative effects on cellular functions of the ımmune system and inflammatory cells might cause chronic and pathological lesions in healthy and diseased periodontal tissues.
6. Specialised immunoresolvents comprise endogeneous molecules including resolvins, lipoxins, protectins and maresins, which actively drive the termination of the inflammation.
Ethics approval(s)Local ethics committee of the Dental School of Ankara University, 19/07/2011, reference number B.30.2.ANK.0.21.63.00/824-02/9-8
Health condition(s) or problem(s) studiedPeriodontial disease is a leucocyte-mediated inflammatory disease characterised by inflammation of the supporting tissues of the teeth induced by micro-organisms that stimulate the host immune and inflammatory responses.
InterventionGingival crevicular fluid samples will be obtained from the orifice of the gingival pocket, using commercially available periopaper strips for the assessment of:
1. Plaque index
2. Gingival index
3. Probing depth
4. Clinical attachment level
5. Bleeding on probing
Intervention typeOther
Primary outcome measure1. Silness and Loe plaque index
2. Loe and Silness gingival index
3. Probing pocket depth
4. Clinical attachment level
5. Bleeding on probing

Clinical measurements will be performed on six sites per tooth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingua and, disto-lingual) using a Williams periodontal probe calibrated in millimetres on the patient's first visit to have periodontal treatment.
Secondary outcome measuresN/A
Overall study start date01/09/2012
Completion date30/03/2014

Eligibility

Participant type(s)Other
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants15 smokers and 15 non-smoker participants
Key inclusion criteria1. Smokers (≥ 5 years of duration and ≥ 15 cigarettes per day)
2. Non-smokers (never smoked)
3. Age ≥ 18 years old
4. ≥ 16 teeth
Key exclusion criteria1. History of cancer
2. History of rheumatoid arthritis
3. History of diabetes mellitus
4. History of cardiovascular diseases
5. Compromised immune system
6. Pregnancy
7. Menopause
8. Lactating
9. Ongoing drug therapy that may affect the clinical features of periodontitis
10. Systemic antimicrobials during the 6 weeks preceding the baseline examination
11. Any dental treatment during the past 6 months
Date of first enrolment01/09/2012
Date of final enrolment30/03/2014

Locations

Countries of recruitment

  • Türkiye

Study participating centre

Ondokuz Mayıs University
Dental Faculty
Samsun
55139
Türkiye

Sponsor information

Ondokuz Mayıs University
University/education

Dental Faculty
Samsun
55139
Türkiye

ROR logo "ROR" https://ror.org/028k5qw24

Funders

Funder type

University/education

Ondokuz Mayıs University (Turkey)

No information available

Results and Publications

Intention to publish date31/03/2015
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanning to send the manuscript for publication in March 2015
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2016 22/01/2019 Yes No

Editorial Notes

22/01/2019: Publication reference added